Mitsuhiro Itagaki

发表

Correction: Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma

H. Asaoku, M. Toyota, Hiromu Suzuki, 2013, Genome Medicine.

Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma

H. Asaoku, M. Toyota, Hiromu Suzuki, 2012, Genome Medicine.

Efficacy of autologous stem cell transplantation for patients with myeloma having suboptimal response: A multicenter retrospective analysis.

K. Kawamura, Y. Kanda, N. Tsukada, 2023, Transplantation and cellular therapy.

Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma

H. Asaoku, J. Kuroda, C. Nakaseko, 2018, Hematological oncology.

Successful haploidentical stem cell transplantation with prophylactic administration of liposomal amphotericin B after invasive pulmonary zygomycosis

H. Asaoku, M. Itagaki, K. Iwato, 2017, Medical mycology case reports.

Trends of survival in patients with multiple myeloma in Japan: a multicenter retrospective collaborative study of the Japanese Society of Myeloma

H. Asaoku, M. Matsumoto, T. Chou, 2015, Blood Cancer Journal.

Tandem autologous stem cell transplantation in elderly patients with myeloma: A multicenter retrospective analysis

K. Kawamura, Y. Kanda, Kazuhito Suzuki, 2023, European journal of haematology.

A nationwide survey on central nervous system multiple myeloma in Japan: analysis of prognostic and treatment factors that impact survival

I. Hanamura, S. Iida, J. Kuroda, 2021, British journal of haematology.

Survival of Multiple Myeloma Patients Aged 65-70 Years in the Era of Novel Agents and Autologous Stem Cell Transplantation

H. Asaoku, Kunihiko Hayashi, R. Mina, 2014, Acta Haematologica.